BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
+3.38%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.49B
AUM Growth
+$450M
(+22%)
Cap. Flow
+$405M
Cap. Flow
% of AUM
16.29%
Top 10 Holdings %
Top 10 Hldgs %
43.41%
Holding
209
New
33
Increased
83
Reduced
31
Closed
36
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$139M |
| 2 |
Citigroup
C
|
+$31.7M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$28.7M |
| 4 |
Linde
LIN
|
+$16.9M |
| 5 |
Microsoft
MSFT
|
+$16.2M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$24.7M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.3M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$8.16M |
| 4 |
Zebra Technologies
ZBRA
|
+$5.33M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$4.79M |
Sector Composition
| 1 | Healthcare | 23.1% |
| 2 | Technology | 17.53% |
| 3 | Consumer Discretionary | 14.48% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Citigroup
C
$183B
| $34.1M | 1.37% |
469,027
+435,080
| +1,282% | +$31.7M |
|
27
Nike
NKE
$108B
| $33.8M | 1.36% |
254,682
+47,110
| +23% | +$6.26M |
|
28
Accenture
ACN
$149B
| $33.3M | 1.34% |
120,619
-568
| -0.5% | -$157K |
|
29
JPMorgan Chase
JPM
$844B
| $30.9M | 1.24% |
203,110
+1,487
| +0.7% | +$226K |
|
30
McDonald's
MCD
$218B
| $28.1M | 1.13% |
125,295
+21,206
| +20% | +$4.75M |
|
31
Boston Scientific
BSX
$152B
| $25.7M | 1.03% |
665,461
+31,473
| +5% | +$1.22M |
|
|
32
Zebra Technologies
ZBRA
$15.9B
| $24.7M | 0.99% |
50,920
-10,980
| -18% | -$5.33M |
|
33
Colgate-Palmolive
CL
$67.3B
| $24.5M | 0.99% |
310,793
+64,500
| +26% | +$5.08M |
|
34
Align Technology
ALGN
$9.54B
| $23.8M | 0.96% |
43,879
-348
| -0.8% | -$188K |
|
35
Walt Disney
DIS
$208B
| $22.6M | 0.91% |
122,290
+15,605
| +15% | +$2.88M |
|
|
36
Linde
LIN
$226B
| $21.5M | 0.87% |
76,720
+60,046
| +360% | +$16.9M |
|
37
Honeywell
HON
$134B
| $19.1M | 0.77% |
88,021
+18,802
| +27% | +$4.08M |
|
38
Abbott
ABT
$233B
| $18.4M | 0.74% |
153,676
+23,327
| +18% | +$2.8M |
|
39
Wells Fargo
WFC
$261B
| $17.4M | 0.7% |
445,766
+205,998
| +86% | +$8.05M |
|
40
SPDR S&P 500 ETF Trust
SPY
$670B
| $17.3M | 0.7% |
43,689
+4,252
| +11% | +$1.68M |
|
41
iShares S&P 500 Value ETF
IVE
$41.2B
| $16.9M | 0.68% |
119,390
+10,470
| +10% | +$1.48M |
|
42
Cognizant
CTSH
$33.8B
| $15.2M | 0.61% |
194,813
+38,131
| +24% | +$2.98M |
|
43
SPDR S&P Biotech ETF
XBI
$5.43B
| $14.8M | 0.6% |
+109,390
| New | +$14.8M |
|
44
3M
MMM
$84.1B
| $14.6M | 0.59% |
90,776
+21,408
| +31% | +$3.45M |
|
45
Chevron
CVX
$317B
| $14.4M | 0.58% |
137,429
+134,317
| +4,316% | +$14.1M |
|
46
Mondelez International
MDLZ
$80.2B
| $14.4M | 0.58% |
245,236
+7,541
| +3% | +$441K |
|
47
Electronic Arts
EA
$43.1B
| $13.3M | 0.53% |
97,896
+17,029
| +21% | +$2.31M |
|
|
48
iShares Core S&P 500 ETF
IVV
$675B
| $12.8M | 0.51% |
32,165
-20,510
| -39% | -$8.16M |
|
49
Merck
MRK
$207B
| $12.7M | 0.51% |
172,248
+35,288
| +26% | +$2.6M |
|
|
IIAC.U
50
DELISTED
Investindustrial Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
IIAC.U
| $12.6M | 0.51% |
1,290,000
| – | – |
|